Skip to main content
. 2021 May 17;6(21):13742–13755. doi: 10.1021/acsomega.1c01032

Figure 1.

Figure 1

Flow chart summarizing the designed vaccine. Several phases are involved in this approach: potential epitope prediction from the antigenic proteins and construction, evaluation, and validation of the multi-epitope vaccine construct; disulfide engineering and molecular docking with chicken immune receptors; and finally, codon adaptation and in silico cloning.